Full Text
The Full Text of this article is available as a PDF (464.9 KB).
Footnotes
Members of the New York City HIV Epidemiology Group are J. Fordvce, S. W. Forlenza, H. Makki, B. Mojica, D. Nash, V. Peters, J. Sackoff, S. Schwartz, T. P. Singh, P. Thomas, I. Torian, and I. Weisfuse.
References
- 1.Chiasson MA, Berenson L, Li W, et al. Declining HIV/AIDS mortality in New York City. J AIDS. 1999;21:59–64. doi: 10.1097/00126334-199905010-00008. [DOI] [PubMed] [Google Scholar]
- 2.Fordyce EJ, Singh TP, Vazquez FM, et al. Evolution of an urban epidemic: the first 100,000 AIDS cases in New York City. Popul Res Policy Rev. 1999;18:523–544. doi: 10.1023/A:1006214312764. [DOI] [Google Scholar]
- 3.Selik RM, Ward JW, Buehler JW. Trends in transfusion-associated acquired immune deficiency syndrome in the United States, 1982–1991. Transfusion. 1993;33:890–893. doi: 10.1046/j.1537-2995.1993.331194082377.x. [DOI] [PubMed] [Google Scholar]
- 4.HIV/AIDS Surveillance Program. New York City Children Perinatally Exposed to HIV—Semiannual Surveillance Update. New York, NY: New York City Department of Health; 2001. [Google Scholar]
- 5.Thomas P, O'Donnell R, Williams R, Chiasson MA. HIV infection in heterosexual female intravenous drug users in New York City, 1977–80. N Engl J Med. 1988;11:374–374. [PubMed] [Google Scholar]
- 6.Centers for Disease Control and Prevention Kaposis's sarcoma and Pneumocystis pneumonia among homosexual men—New York City and California. MMWR Morb Mortal Wkly Rep. 1981;30:305–308. [PubMed] [Google Scholar]
- 7.Barre-Sinoussi F, Chermann JC, Rey F, et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS) Science. 1983;220:868–871. doi: 10.1126/science.6189183. [DOI] [PubMed] [Google Scholar]
- 8.Weiss SH, Goedert JJ, Sarngadharan MG, et al. Screening test for HTLV-III (AIDS agent) antibodies. Specificity, sensitivity, and applications. JAMA. 1985;253:221–225. doi: 10.1001/jama.253.2.221. [DOI] [PubMed] [Google Scholar]
- 9.New York State Public Health Law. Laws of 1998, ch 163, article 21, title III. July 1998.
- 10.New York State Sanitary Code, §24.1, 24.2, and Public Health Law 206 (1)(j) 10/31/83.
- 11.Greenberg AE, Hinden R, Nicholas AG, Bryan EL, Thomas PA. The completeness of AIDS case reporting in New York City. JAMA. 1993;269:2995–3001. doi: 10.1001/jama.269.23.2995. [DOI] [PubMed] [Google Scholar]
- 12.Thomas PA, Weisfuse IB, Greenberg AE, et al. Trends in the first 10 years of AIDS in New York City. Am J Epidemiol. 1993;137:121–133. doi: 10.1093/oxfordjournals.aje.a116652. [DOI] [PubMed] [Google Scholar]
- 13.Stoneburner R, Chiasson MA, Weisfuse IB, et al. The epidemic of AIDS and HIV-1 infection among heterosexuals in New York City. AIDS. 1990;4:99–106. doi: 10.1097/00002030-199002000-00001. [DOI] [PubMed] [Google Scholar]
- 14.HIV/AIDS Surveillance Report 1999. Atlanta, GA: Centers for Disease Control and Prevention; 1999. [Google Scholar]
- 15.Summary of Vital Statistics, 1999. New York, NY: New York City Department of Health; 1999. [Google Scholar]
- 16.Fordyce EJ, Shum R, Singh TP, Forlenza S. Economic and geographic diversity in AIDS incidence among HIV exposure groups in New York City: 1983 to 1985. AIDS Public Policy J. 1998;4(3):103–114. [PubMed] [Google Scholar]
- 17.AIDS in the Boroughs and Neighborhoods of New York City. New York, NY: New York City Department of Health; 1998. [Google Scholar]
- 18.Edlin BR, Irwin KL, Faruques S, et al. Intersecting epidemics—crack cocaine use and HIV infection among inner-city young adults. NEJM. 1994;331:1422–1427. doi: 10.1056/NEJM199411243312106. [DOI] [PubMed] [Google Scholar]
- 19.AIDS New York City. HIV/AIDS Surveillance Program. New York, NY: New York City Department of Health; 2001. [Google Scholar]
- 20.Comprehensive Newborn Testing Program. Annual Summary Report. Albany, NY: New York State Department of Health; 1999. [Google Scholar]
- 21.Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission rates of human immunodeficiency syndrome virus type 1 with zidovudine treatment. N Engl J Med. 1994;331:1173–1180. doi: 10.1056/NEJM199411033311801. [DOI] [PubMed] [Google Scholar]
- 22.Hogg RS, Heath KV, Yip B, et al. Improved survival among HIV infected individuals following initiation of antiretroviral therapy. JAMA. 1998;279:450–457. doi: 10.1001/jama.279.6.450. [DOI] [PubMed] [Google Scholar]
- 23.Summary of Vital Statistics 1999. New York, NY: Office of Vital Statistics, New York City Department of Health; 1999. [Google Scholar]
- 24.Gwinn M, Pappaioanou M, George JR, et al. Prevalence of HIV infection in childbearing women in the United States. Surveillance using newborn blood samples. JAMA. 1991;265(13):1704–1708. doi: 10.1001/jama.265.13.1704. [DOI] [PubMed] [Google Scholar]
- 25.HIV Seroprevalence Update 1999. New York, NY: AIDS Research/HIV Serosurvey Program; 1999. [Google Scholar]
- 26.Torian LV, Koblin BA, Guilin VA, et al. High seroprevalence with wide racial differentials in young men who have sex with men sampled at public venues in New York City, 1999–2000. Paper presented at: Eighth Conference on Retroviruses and Opportunistic Infections; February 4, 2001; Chicago, IL. Abstract 212.
- 27.Janssen RS, Satten GA, Stramer SL, et al. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA. 1998;280:42–48. doi: 10.1001/jama.280.1.42. [DOI] [PubMed] [Google Scholar]
- 28.Jarlais DC, Marmor M, Friedman P, Titus S, et al. HIV incidence among injection drug users in New York City, 1992–1997: evidence for a declining epidemic. Am J Pub Health. 2000;90:352–359. doi: 10.2105/AJPH.90.3.352. [DOI] [PMC free article] [PubMed] [Google Scholar]